[Double blind comparison between imidazole-2-hydroxybenzoate and diclofenac sodium in the treatment of osteoarthrosis in geriatric patients]. 1985

M Pagano, and M Sapienza, and C Fuschi, and I Nardi

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Pagano, and M Sapienza, and C Fuschi, and I Nardi
August 1985, Bollettino chimico farmaceutico,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
August 1985, Bollettino chimico farmaceutico,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
January 1978, Scandinavian journal of rheumatology. Supplement,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
May 1981, The Practitioner,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
August 1985, Bollettino chimico farmaceutico,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
January 1991, European journal of rheumatology and inflammation,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
August 1985, Bollettino chimico farmaceutico,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
August 1985, Bollettino chimico farmaceutico,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
August 1985, Bollettino chimico farmaceutico,
M Pagano, and M Sapienza, and C Fuschi, and I Nardi
June 1984, Ryumachi. [Rheumatism],
Copied contents to your clipboard!